NSC5844
CAS No. 140926-75-6
NSC5844 ( NSC5844 | NSC-5844 | NSC 5844 | RE640 )
产品货号. M17281 CAS No. 140926-75-6
NSC5844 (RE640) 是一种双喹啉化合物,具有 CC 趋化因子受体 1 型 (CCR1) 激动活性。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥449 | 有现货 |
|
| 5MG | ¥848 | 有现货 |
|
| 10MG | ¥1131 | 有现货 |
|
| 25MG | ¥1600 | 有现货 |
|
| 50MG | ¥2325 | 有现货 |
|
| 100MG | ¥3222 | 有现货 |
|
| 200MG | ¥4248 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称NSC5844
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述NSC5844 (RE640) 是一种双喹啉化合物,具有 CC 趋化因子受体 1 型 (CCR1) 激动活性。
-
产品描述NSC5844, also known as RE640, is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.
-
体外实验NSC5844 (Compound 10) is a 4-aminoquinoline derivative, and has antitumor activity with GI50s of 7.35 ± 0.10 μM and 14.80 ± 0.35 μM against MDA-MB-468 and MCF-7 cells, respectively. NSC5844 (Compound 1) is cytotoxic to P. falciparum, inhibits the growth of chloroquine-sensitive (D-6) and -resistant (W-2) clones of P. falciparum, with IC50s of 17 and 27 nM, respectively.
-
体内实验——
-
同义词NSC5844 | NSC-5844 | NSC 5844 | RE640
-
通路PI3K/Akt/mTOR signaling
-
靶点PI3K
-
受体CCR1
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number140926-75-6
-
分子量383.27
-
分子式C20H16Cl2N4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 1 mg/mL (2.61 mM)
-
SMILESc1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl
-
化学全称N,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Zhang H, et al. Biomed PharmacOthers. 2008 Feb;62(2):65-9.
产品手册
关联产品
-
PIK-108
PIK-108 是磷脂酰肌醇-4,5-二磷酸 3-激酶催化亚基 β 和 δ (PI3Kβ/δ) 的变构抑制剂。
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
GS-9901
GS-9901 是高度选择性的、口服有效的 PI3Kδ 的抑制剂,其 IC50 值为 1 nM。有用于风湿性关节炎的潜能。
021-51111890
购物车()
sales@molnova.cn

